Skip to main content

Table 2 Case series/reports investigating intermittent fasting in patients with type 2 diabetes

From: Intermittent fasting: is there a role in the treatment of diabetes? A review of the literature and guide for primary care physicians

Intermittent Fasting Protocol Description Effects of Intermittent Fasting vs. Baseline
Alternate Day Fasting One day of fasting/One day of ad libitum feeding Furmli et al. [26] (7 months) Average Baseline Values:
HbA1C: 11%, 96.7 mmol/mol
Body weight: 83.8 kg
Results:
- Decreased HbA1C by 4%
- Decreased body weight by 10 kg
  Furmli et al. [26] (11 months) Average Baseline Values:
HbA1C: 7.2%, 55.2 mmol/mol
Body weight: 61 kg
Results:
- Decreased HbA1C by 0.8%
- Decreased body weight by 9 kg
Furmli et al. [26] (11 months) Average Baseline Values:
HbA1C: 6.8%, 50.8 mmol/mol
Body weight: 97.1 kg
Results:
- Decreased HbA1C by 1.2%
- Decreased body weight by 10.6 kg
Lichtash et al. [27] (14 months) Average Baseline Values
HbA1C: 9.3%
Body Weight: 55.3 kg
Results:
- Decreased HbA1C by 3.5%
- Decreased body weight by 1.8 kg